These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2413592)

  • 1. Transplantation tolerance mediated by suppressor T cells and suppressive antibody in a recipient of a renal transplant.
    Suzuki S; Mizuochi I; Sada M; Amemiya H
    Transplantation; 1985 Oct; 40(4):357-63. PubMed ID: 2413592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human suppressor T cells induced in vitro with an autologous renal allograft-derived T cell line. I. Suppressor cell induction, function, and specificity.
    Emara M; Miceli MC; Finn OJ; Sanfilippo F
    Hum Immunol; 1988 Nov; 23(3):223-40. PubMed ID: 2976413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of IL-2 synthesis by donor-specific suppressor T cells in a renal transplant recipient.
    Okimoto T; Yahata H; Fukuda Y; Hayamizu K; Dohi K
    Transpl Int; 1994; 7 Suppl 1():S629-33. PubMed ID: 11271325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-idiotypic antibodies in a patient with a well-functioning renal graft without azathioprine. II. Anti-idiotypic antibodies directed to a clonotype of a certain cytotoxic T lymphocyte.
    Miyajima T; Shimizu R; Kuzuhara H; Fujimoto S
    Int Immunol; 1989; 1(5):503-8. PubMed ID: 2535140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation.
    Otten HG; Calis JJ; Keşmir C; van Zuilen AD; Spierings E
    Hum Immunol; 2013 Mar; 74(3):290-6. PubMed ID: 23232063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The mechanism of donor specific unresponsiveness in renal transplant recipients].
    Okimoto T; Yahata H; Fukuda Y; Dohi K
    Nihon Rinsho Meneki Gakkai Kaishi; 1998 Jun; 21(3):118-28. PubMed ID: 9754014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biologic significance of the mixed lymphocyte kidney culture in humans.
    Roth D; Fuller L; Esquenazi V; Kyriakides GK; Pardo V; Miller J
    Transplantation; 1985 Oct; 40(4):376-83. PubMed ID: 2996186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of OKT 8 antigen and Fc gamma receptors by suppressor cells mediating specific unresponsiveness between recipient and donor in renal-allograft-tolerant patients.
    Charpentier BM; Bach MA; Lang P; Fries D
    Transplantation; 1983 Nov; 36(5):495-501. PubMed ID: 6227112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. The implications for graft survival.
    ten Hoor GM; Coopmans M; Allebes WA
    Transplantation; 1993 Aug; 56(2):298-304. PubMed ID: 7689256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation.
    Chu E; Umetsu D; Rosen F; Geha RS
    J Clin Invest; 1983 Sep; 72(3):1124-9. PubMed ID: 6193142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of antiidiotypic antibodies by donor-specific blood transfusions. Establishment of a human-mouse hybridoma secreting the MLR-inhibiting factor.
    Kawamura T; Sakagami K; Haisa M; Morisaki F; Takasu S; Inagaki M; Oiwa T; Orita K
    Transplantation; 1989 Sep; 48(3):459-63. PubMed ID: 2528850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human suppressor T cells induced in vitro with an autologous renal allograft-derived T cell line. II. Activity and specificity of a soluble suppressor factor.
    Emara M; Sanfilippo F
    Transplantation; 1989 Feb; 47(2):364-71. PubMed ID: 2521964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production in vitro of antibodies directed against alloantigen-specific recognition sites on T cells and on lymphocytotoxic HLA antibodies.
    Singal DP; Blajchman MA; Joseph S; Roberge B; Smith EK; Ludwin D
    Clin Exp Immunol; 1988 May; 72(2):222-7. PubMed ID: 2970351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro generation of human mixed lymphocyte culture suppressor cells. I. Cellular characterization and specificity.
    Fuller L; Kyriakides G; Flaa C; Esquenazi V; Miller J
    Transplantation; 1980; 29(1):54-60. PubMed ID: 6445100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful unintentional ABO-incompatible renal transplantation: Blood group A1B donor into an A2B recipient.
    Fadeyi EA; Stratta RJ; Farney AC; Pomper GJ
    Am J Clin Pathol; 2014 May; 141(5):724-6. PubMed ID: 24713746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of antiidiotypic antibodies to donor HLA that develop after liver transplantation.
    Chauhan B; Phelan DL; Marsh JW; Mohanakumar T
    Transplantation; 1993 Aug; 56(2):443-8. PubMed ID: 7689260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic suppressive effects of pregnancy sera on monocytes of responding cells in human mixed lymphocyte reactions.
    Nieda M; Juji T; Imao S
    J Clin Invest; 1985 Oct; 76(4):1477-84. PubMed ID: 2932467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity.
    Strober S; Benike C; Krishnaswamy S; Engleman EG; Grumet FC
    Transplantation; 2000 Apr; 69(8):1549-54. PubMed ID: 10836360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MLC-specific suppressor T lymphocytes in man. I. Their induction in vitro by soluble HLA-DR antigens.
    Smeraldi RS; Fabio G; Bonara P; Villa MG; Vanoli M; Pettenati C; Rugarli C; Zanussi C
    J Immunol; 1982 Mar; 128(3):1394-8. PubMed ID: 6173435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.